Recent Quotes
My Watchlist
Indicators
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

17.24 -2.09 (-10.81%)
Official Closing Price Updated: 7:00 PM EST, Feb 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 51,694,296
Open 18.70
Bid (Size) 17.30 (200)
Ask (Size) 17.45 (4,000)
Prev. Close 19.33
Today's Range 17.20 - 19.38
52wk Range 16.35 - 72.98
Shares Outstanding 191,922,517
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Hoth Therapeutics's GDNF Treatment Shows Superior Efficacy Over Wegovy, Ozempic In Preclinical Trial ↗
The company announced positive preclinical results from a study evaluating GDNF as a potential treatment for obesity and metabolic-associated steatotic liver disease. 
Via Stocktwits
News headline image
The Vertical Integration of Wellness: A Deep Dive into Hims & Hers Health (HIMS)
Today is February 10, 2026. The telehealth landscape stands at a historic inflection point, and no company better embodies this volatility than Hims & Hers Health, Inc. (NYSE: HIMS). After a meteoric... 
Via Finterra
Topics Artificial Intelligence Intellectual Property Lawsuit

Performance

YTD
-48.4%
-48.4%
1 Month
-46.7%
-46.7%
3 Month
-56.6%
-56.6%
6 Month
-64.1%
-64.1%
1 Year
-61.5%
-61.5%

More News

Read More
News headline image
Stocks making big moves yesterday: Shopify, Snowflake, Ryan Specialty, Merchants Bancorp, and Hims & Hers Health
Via StockStory
Topics Stocks
FDA "Swift Action" Warning Sends Hims & Hers into a Tailspin ↗
Via Chartmill
Dow Futures Push Higher After Breaking 50,000: Why OPGN, ACHR, LI, HIMS, CING Are Trending Today ↗
Via Stocktwits
Topics Stocks
Dow 50,000 is No Longer a Mirage, but the "Accounting Ghost" Haunts Tech ↗
Via Chartmill
Topics Stocks
News headline image
Stock Market Today, Feb. 9: Hims & Hers Health Drops 16% on Novo Nordisk Lawsuit ↗
Via The Motley Fool
Topics Artificial Intelligence Lawsuit Stocks
News headline image
Hims & Hers Collapses After FDA Vows to Restrict Copycat GLP-1 Pill. Is the Stock Toast? ↗
Via The Motley Fool
Topics Intellectual Property Lawsuit
News headline image
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Novo Nordisk vs. Eli Lilly: What's the Better Long-Term Investment? ↗
Via The Motley Fool
Topics Intellectual Property
Which stocks are most active on Monday? ↗
Via Chartmill
News headline image
Why Novo Nordisk Stock Just Popped ↗
Via The Motley Fool
Topics Intellectual Property Lawsuit
Which stocks are experiencing notable movement on Monday? ↗
Via Chartmill
News headline image
Why Hims & Hers Stock Just Got Destroyed ↗
Via The Motley Fool
Topics Lawsuit
News headline image
Why Hims & Hers Health (HIMS) Stock Is Nosediving
Via StockStory
Topics Intellectual Property Lawsuit
News headline image
The GLP-1 Gold Rush Hits a Wall: Novo Nordisk Sues Hims & Hers as FDA Crackdown Triggers 20% Stock Crash
Via MarketMinute
Topics Intellectual Property Lawsuit
News headline image
FDA Says Novo's Wegovy Pill TV Advertisement Is Misleading: NVO Stock Pares Gains ↗
Via Stocktwits
Topics Lawsuit
News headline image
Why Eli Lilly Stock Just Popped ↗
Via The Motley Fool
Topics Lawsuit
The market is filled with gapping stocks in Monday's session. ↗
Via Chartmill
News headline image
The GLP-1 Gold Rush Hits a Wall: Hims & Hers Shares Crater After Abrupt Oral Wegovy U-Turn
Via MarketMinute
Topics Earnings Intellectual Property
News headline image
The GLP-1 Reckoning: Why Hims & Hers (HIMS) Pivoted and Shed 20% of Its Value
Via Finterra
Topics Earnings Economy Intellectual Property
Monday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
Novo Nordisk Sues Hims & Hers Over Compounded Wegovy, Calls For Permanent Sales Ban: HIMS Stock Tanks ↗
Via Stocktwits
Topics Intellectual Property Lawsuit
Dow 50,000: A Milestone for the History Books Amidst an AI Spending War ↗
Via Chartmill
Topics Artificial Intelligence Stocks
News headline image
HIMS Stock In Turmoil: Retail Bulls Bet On Rebound, Skeptics See Bloodbath After Compounded Weight-Loss Pill Halt ↗
Via Stocktwits
Topics Intellectual Property Law Enforcement

Frequently Asked Questions

Is Hims & Hers Health, Inc. Class A Common Stock publicly traded?
Yes, Hims & Hers Health, Inc. Class A Common Stock is publicly traded.
What exchange does Hims & Hers Health, Inc. Class A Common Stock trade on?
Hims & Hers Health, Inc. Class A Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Hims & Hers Health, Inc. Class A Common Stock?
The ticker symbol for Hims & Hers Health, Inc. Class A Common Stock is HIMS on the New York Stock Exchange
What is the current price of Hims & Hers Health, Inc. Class A Common Stock?
The current price of Hims & Hers Health, Inc. Class A Common Stock is 17.24
When was Hims & Hers Health, Inc. Class A Common Stock last traded?
The last trade of Hims & Hers Health, Inc. Class A Common Stock was at 02/10/26 07:00 PM ET
What is the market capitalization of Hims & Hers Health, Inc. Class A Common Stock?
The market capitalization of Hims & Hers Health, Inc. Class A Common Stock is 3.31B
How many shares of Hims & Hers Health, Inc. Class A Common Stock are outstanding?
Hims & Hers Health, Inc. Class A Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>